{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:07:34Z","timestamp":1787242054288,"version":"build-2736575974"},"reference-count":17,"publisher":"SLACK, Inc.","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Orthopedics"],"published-print":{"date-parts":[[1998,10]]},"abstract":"<jats:p>ABSTRACT<\/jats:p>\n                  <jats:p>Orgaran (danaparoid sodium injection) is a novel antithrombotic agent. Early studies suggest that this compound may be beneficial in preventing deep vein thrombosis in predisposed patients. This multicenter, randomized, assessor blinded, clinical trial compared subcutaneous danaparoid with warfarin for the prevention of deep vein thrombosis in patients undergoing hip replacement surgery. Bilateral venography was used to detect thrombi. Patients also underwent follow-up examinations 1, 2, and 3 months after discontinuation of the study to determine the after effects of treatment.<\/jats:p>\n                  <jats:p>Nearly 27% of patients who received warfarin and 14.6% of patients who received danaparoid developed deep vein thrombosis, a risk reduction of 46%. The absolute difference in the incidence of deep vein thrombosis was 12.3% in favor of danaparoid. The incidence of venographically documented proximal deep vein thrombosis was 1.5% for danaparoid and 4.1% for warfarin. These results demonstrate that danaparoid is more effective than warfarin in preventing deep vein thrombosis following hip replacement surgery. The preoperative administration of danaparoid does not increase surgical blood loss compared with warfarin.<\/jats:p>","DOI":"10.3928\/0147-7447-19981001-11","type":"journal-article","created":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T07:58:01Z","timestamp":1618991881000},"page":"1123-1128","source":"Crossref","is-referenced-by-count":19,"title":["A Comparison of Danaparoid and Warfarin for Prophylaxis Against Deep Vein Thrombosis After Total Hip Replacement"],"prefix":"10.3928","volume":"21","author":[{"given":"Philip C","family":"Comp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Voegeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W","family":"McCutchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasilios A","family":"Skoutakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Trowbridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William L","family":"Overdyke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2308","reference":[{"key":"e_1_3_1_2_1","doi-asserted-by":"crossref","unstructured":"1. Clagett GP. Prevention of postoperative venous thromboembolism: an update. Am J Surg. 1994; 168:515-522.","DOI":"10.1016\/S0002-9610(05)80114-X"},{"key":"e_1_3_1_3_1","doi-asserted-by":"crossref","unstructured":"2. O'Meara PM. Kaufman EE. Prophylaxis for venous thromboembolism in total hip arthroplasty: a review. Ortiiopedics. 1990; 13:173-178.","DOI":"10.3928\/0147-7447-19900201-07"},{"key":"e_1_3_1_4_1","doi-asserted-by":"crossref","unstructured":"3. Kakkar W. Prevention and management of venous thrombosis. Br Med Bull. 1994; 50:871-903.","DOI":"10.1093\/oxfordjournals.bmb.a072931"},{"key":"e_1_3_1_5_1","doi-asserted-by":"crossref","unstructured":"4. Lieberman JR Geerts WH. Prevention of venous thromboembolism after total hip and knee arthroplasty. J Bone Joint Surg Am. 1994; 76:1239-1250.","DOI":"10.2106\/00004623-199408000-00015"},{"key":"e_1_3_1_6_1","doi-asserted-by":"crossref","unstructured":"5. Danhof M de Boer A. Magnani HN Stiekema JC Pharmacokinetic considerations on Orgaran (Org 10172) therapy Haemostasis. 1992;22:73-84.","DOI":"10.1159\/000216298"},{"key":"e_1_3_1_7_1","doi-asserted-by":"crossref","unstructured":"6. Meuleman DG. Orgaran (Org 10172): its pharmacological profile in experimental models. Haemostasis. 1992; 22:58-65.","DOI":"10.1159\/000216296"},{"key":"e_1_3_1_8_1","doi-asserted-by":"crossref","unstructured":"7. de VaIk HW Banga JD Wester JW. et al. Comparing subcutaneous danaparoid with intravenous unfractionated heparin for the treatment of venous thromboembolism. A randomized controlled trial. Ann Intern Med. 1995: 123:1-9.","DOI":"10.7326\/0003-4819-123-1-199507010-00001"},{"key":"e_1_3_1_9_1","doi-asserted-by":"crossref","unstructured":"8. Gerhart TN Yett HS Robertson LK. Lee MA Smith M Satzman EW. Low-molecularweight heparinoid compared with warfarin for prophylaxis of deep-vein Uirombosis in patients who are operated on for fracture of the hip. A prospective randomized trial. J Bone Joint Surg Am. 1991;73:494-502.","DOI":"10.2106\/00004623-199173040-00003"},{"key":"e_1_3_1_10_1","unstructured":"9. Estoppey D Hockreither J Breyer HG et al. Org 10172 (Lomoparan) versus heparin-DHE in prevention of mromboemboHsm in total hip replacement - a multicentre trial. Thromb Haemost. 1989; 62:356. Abstract."},{"key":"e_1_3_1_11_1","doi-asserted-by":"crossref","unstructured":"10. Ten Cate JW. Prevention of deep vein thrombosis following total hip replacement surgery by Orgaran. Summary. Haemostasis. 1992;22:109-111.","DOI":"10.1159\/000216303"},{"key":"e_1_3_1_12_1","doi-asserted-by":"crossref","unstructured":"11. Rabinov K Paulin S. Roentgen diagnosis of venous thrombosis in the leg. Arch Surg. 1 972; 104:134-144.","DOI":"10.1001\/archsurg.1972.04180020014004"},{"key":"e_1_3_1_13_1","doi-asserted-by":"crossref","unstructured":"12. Hull R Raskob G Pineo G et al. A comparison of subcutaneous low-molecular-weight heparin witfi warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation. N Engl J Med. 1993; 329:1370-1376.","DOI":"10.1056\/NEJM199311043291902"},{"key":"e_1_3_1_14_1","doi-asserted-by":"crossref","unstructured":"13. Imperiale TF. Speroff. A meta-analysis of methods to prevent venous mromboemboUsm following total hip replacement. JAMA. 1994; 271:1780-1785.","DOI":"10.1001\/jama.271.22.1780"},{"key":"e_1_3_1_15_1","doi-asserted-by":"crossref","unstructured":"14. Davidson BL Elliott CG Lensing AW. Low accuracy of color Doppler ultrasound in the detection of proximal leg vein thrombosis in asymptomatic high-risk patients. The RD Heparin Arthroplasty Group. Ann Intern Med. 1992; 117:735-738.","DOI":"10.7326\/0003-4819-117-9-735"},{"key":"e_1_3_1_16_1","doi-asserted-by":"crossref","unstructured":"15. Wells PS Lensing AW Davidson BL Prins MH Hirsh J. Accuracy of ultrasound for the diagnosis of deep venous thrombosis in asymptomatic patients after orthopedic surgery. A meta-analysis. Ann Intern Med. 1995; 122:47-53.","DOI":"10.7326\/0003-4819-122-1-199501010-00008"},{"key":"e_1_3_1_17_1","doi-asserted-by":"crossref","unstructured":"16. Kearon C Hirsh J. Starting prophylaxis for venous thromboembolism postoperatively. Arch tntern Med. 1995; 155:366-372.","DOI":"10.1001\/archinte.155.4.366"},{"key":"e_1_3_1_18_1","doi-asserted-by":"crossref","unstructured":"17. RD Heparin Arthroplasty Group. RD heparin compared wit\u00eci warfarin for prevention of venous thromboembolic disease following total hip or knee arthroplasty. RD Heparin Arthroplasty Group. J Bone Joint Surg Am. 1994; 76:1174-1185.","DOI":"10.2106\/00004623-199408000-00008"}],"container-title":["Orthopedics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T23:15:29Z","timestamp":1683069329000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.healio.com\/doi\/10.3928\/0147-7447-19981001-11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,10]]},"references-count":17,"journal-issue":{"issue":"10","published-print":{"date-parts":[[1998,10]]}},"alternative-id":["10.3928\/0147-7447-19981001-11"],"URL":"https:\/\/doi.org\/10.3928\/0147-7447-19981001-11","relation":{},"ISSN":["0147-7447","1938-2367"],"issn-type":[{"value":"0147-7447","type":"print"},{"value":"1938-2367","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,10]]}}}